Liposarcoma Treatment Market : Global Industry Analysis and Forecast 2016 - 2022

Liposarcoma Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Persistence Market Research
Liposarcoma Treatment Market : Global
Industry Analysis and Forecast 2016 - 2022
Persistence Market Research
1
Liposarcoma Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Persistence Market Research Released New Market Report on “Liposarcoma Treatment
Market : Global Industry Analysis and Forecast 2016 - 2022”.
Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in
retroperitoneum or thighs. According to WHO, liposarcoma is the most common type of
sarcomas (cancer of soft tissue) and accounts for approximately 17-20% of all cases of
sarcoma. However, WHO classifies liposarcoma in the rare diseases as the incidence rate of
the disease is as low as 2.5 per Mn population. Liposarcoma most commonly occurs in the
middle age or adults above the age of 40 and it can be well diagnosed with the help of excision
biopsy. Liposarcoma can be of four types viz. well differentiated liposarcoma, myxoid
liposarcoma, pleomorphic liposarcoma and dedifferentiated liposarcoma. The most common
drugs used for the treatment of liposarcoma include ifosfamide and doxorubicin. Ifosfamide is
often prescribed in combination with uromitexan in order to prevent bladder irritation and internal
bleeding. Moreover, cisplatin, vincristine, etoposide, gemcitabine, docetaxel etc. can be used to
prevent the recurrence of liposarcoma.
The market for liposarcoma is highly fragmented with large number of generic manufacturers.
The global market for liposarcoma treatment is expected to grow moderately over the forecast
period owing to low incidence rate of the disease. Some other factors which are anticipated to
influence growth of global liposarcoma treatment market include lifestyle changes, incidence of
genetic disorders, growing awareness through liposarcoma genome project etc. However, high
cost of the treatment can be the major restraint for the growth of global liposarcoma treatment
market.
Interested in report: Please follow the below links to meet your requirements;
Request for the Report Brochure: http://www.persistencemarketresearch.com/samples/10109
Persistence Market Research
2
Liposarcoma Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
The global liposarcoma treatment market has been classified on the basis of treatment type,
end user and geography.
Based on treatment type, the global liposarcoma treatment market is divided into
following:
•
Chemotherapy
•
Radiation Therapy
•
Surgical Therapy
Request TOC (table of content), Figures and Tables of the Report:
http://www.persistencemarketresearch.com/toc/10109
Based on the end user type, the global liposarcoma treatment market is divided into
following:
•
Hospitals
•
Multispecialty Clinics
•
Cancer treatment and rehabilitation centers
Surgical therapy treatment segment is expected to account for major share in global
liposarcoma treatment market as it is the choice of treatment recommended by majority of
cancer specialists. Most of the physicians do not rely on chemotherapy for the liposarcoma
treatment however, it can be used prior to the surgery to reduce the size of the tumor making it
the second largest segment in terms of value in global liposarcoma treatment market. Radiation
therapy treatment is used to avoid recurrence of the liposarcoma after surgery and contributes a
minimal share in global liposarcoma treatment market.
Persistence Market Research
3
Liposarcoma Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Geographically, global liposarcoma treatment market is classified into five key regions: North
America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is
anticipated to lead the global liposarcoma treatment market due to relatively greater prevalence
of the disease in the region. APAC and MEA regions are expected to witness steady market
growth owing to lack of awareness about the disease.
For more info: http://www.persistencemarketresearch.com/contact-us.asp
Some of the key players in global liposarcoma treatment market include Eli Lilly and Company,
Baxter International, Bristol Laboratories Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd.,
Mylan N.V., Actavis plc.,Fresenius Kabi Ltd., Accord Healthcare Inc., Taro Pharmaceuticals Inc.,
Sandoz, Bedford Laboratories and others. Recently FDA approved the new indication of
Halaven (eribulin) to Esai Co. Ltd. and new drug application of Yondelis (Trabectedin) from
Johnson & Johnson Private Limited for use in Europe, Russia and South Korea.
Follow us on: https://www.linkedin.com/company/persistence-market-research-&-consulting
The report covers exhaustive analysis on:
•
Liposarcoma Treatment Market Segments
•
Liposarcoma Treatment Market Dynamics
•
Historical Actual Market Size, 2013 - 2015
•
Liposarcoma Treatment Market Size & Forecast 2016 to 2022
•
Liposarcoma Treatment Current Trends/Issues/Challenges
•
Competition & Companies involved
•
Liposarcoma Treatment Drivers and Restraints
Persistence Market Research
4
Liposarcoma Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
Regional analysis includes
•
North America
•
Latin America
•
Europe
•
Asia Pacific
•
Middle East & Africa
Report Highlights:
•
Shifting Industry dynamics
•
In-depth market segmentation
•
Historical, current and projected industry size Recent industry trends
•
Key Competition landscape
•
Strategies of key players and product offerings
•
Potential and niche segments/regions exhibiting promising growth
•
A neutral perspective towards market performance
About Us:
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in
syndicated research, custom research, and consulting services. PMR boasts market research
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and
Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping
and Transportation industries. The company draws from its multi-disciplinary capabilities and
high-pedigree team of analysts to share data that precisely corresponds to clients’ business
needs.
Persistence Market Research
5
Liposarcoma Treatment Market : Global Industry Analysis
and Forecast 2016 - 2022
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.
From ready-to-purchase market research reports to customized research solutions, PMR’s
engagement models are highly flexible without compromising on its deep-seated research
values.
Contact Us:
Persistence Market Research
305 Broadway, 7th Floor,
New York City, NY 10007,
United States.
Phone: +1-646-568-7751
USA/Canada Toll Free Number: +1-800-961-0353
E-mail: [email protected]
Web : http://www.persistencemarketresearch.com
Persistence Market Research
6